SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Vertex Pharmaceuticals (VRTX)
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1169 64 0 VRTX
Emcee:  David Lieberman Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
469What is going on with second indication for ICE-i? Didn't JB *projected* secMiljenko Zuanic-12/29/2000
468Tom, <<The first was probably just to grease the wheels.>> IMPDH iMiljenko Zuanic-12/21/2000
467MZ, What do you make of this statement? <<<"In less than one yrkrw-12/21/2000
466<First, second, third,...fifth,...How many IMPDH candidates they need?>>tommysdad-12/21/2000
465First, second, third,...fifth,...How many IMPDH candidates they need? CuriosityMiljenko Zuanic-12/19/2000
464Vertex Announces Start of Clinical Development with VX-148 CAMBRIDGE, Massscaram(o)uche-12/19/2000
463I am glad to read that VRTX is interesting for 50% of NA market. Few more $MM inMiljenko Zuanic-12/12/2000
462Message 15000492scaram(o)uche-12/12/2000
461Jim, I am not one who can give you right answers. All what I did observed is grMiljenko Zuanic-11/22/2000
460Jim: Off the cuff here.... the thymocyte observation, to me, is an indicationscaram(o)uche-11/21/2000
459Miljenko- I have now read the full paper from Peter Ward's lab on C5a andBiotech Jim-11/21/2000
458OT <<"too many mediators in an inflammatory process, what good will Miljenko Zuanic-11/20/2000
457[ OT ] I guess it's OK if we keep meeting here like this. I used to use thscaram(o)uche-11/20/2000
456OT, anti-C5a (ALXN): jci.org J Clin Invest, November 2000, Volume 106, Number Miljenko Zuanic-11/20/2000
455Thank you MZ. Sorry, am not pushing anything. 6.8 mg/kg of 5g1.1sc was safe in keokalani'nui-11/19/2000
454<<OT...did you ever find anything wrong with anti-C5, other than market vaMiljenko Zuanic-11/17/2000
453Thank you MZ. I appreciate it when someone shines the light, even and especiallkeokalani'nui-11/16/2000
452Thanks Wilder. Many companies, mainly big pharma, have active caspases (cysteinMiljenko Zuanic-11/16/2000
451Cytovia also has a promising preclinical caspase inhibitor in ischemia/reperfusikeokalani'nui-11/16/2000
450Tuesday November 14, 2:00 pm Eastern Time Press Release SOURCE: Idun PharmaceutiMiljenko Zuanic-11/14/2000
449I'll give an answer a bit different than Miljenko's. There is little orscaram(o)uche-11/11/2000
448Ahhh, yes, thanks. eomkeokalani'nui-11/11/2000
447ZERO! [EOM]Miljenko Zuanic-11/10/2000
446Anyone here have thoughts on how much VRTX's market cap depends on incel forkeokalani'nui-11/10/2000
445-- S&P SmallCap 600 components Protein Design Labs (NASDAQ:PDLI) and Vertex Miljenko Zuanic-10/25/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News